The transmembrane immune signaling adaptor TYROBP is considered to be involved in Alzheimer's disease (65,66) and as a target of TERC in inflammatory processes (67). In addition, TYROBP is suggested as a prognostic marker for gastric cancer and renal cell carcinoma (68, 69). This evidence concerns the gene TYROBP and early-onset autosomal dominant Alzheimer disease.